Stock Performance

Australia's former healthcare darling hit A$125.78, down 49.91 percent over 12 months and wiping A$60 billion from its market cap after dismal half-year results triggered another confidence collapse. Underlying profit fell 7 percent while reported earnings plunged 81 percent on $1.1 billion in impairments, mostly from intellectual property writedowns at Vifor and Seqirus units. The company's plasma margin recovery to pre-COVID levels has been abandoned entirely, shifting investor expectations from high single-digit growth to low singles with execution risk. Three major downgrades since August 2025 have destroyed management credibility, leaving a blue-chip growth story stranded in value territory with a sub-1.5 percent dividend yield.

The collaboration software maker beat revenue estimates with $1.79 billion in Q3, up 32% year-over-year, and raised full-year growth forecasts from 22% to 24%. Rovo, Atlassian's AI search agent, now has over 5 million monthly active users and is driving enterprise sales that had been stagnating. The stock had fallen 57% year-to-date before this jump, making it one of the more dramatic AI validation stories. The question now is whether other software companies can replicate Atlassian's model of using AI to accelerate existing workflows rather than replace them entirely.

Shares recovered from a 2.5% initial drop to finish up 2.6% at $273 after the company announced Tim Cook's transition to executive chairman and John Ternus's promotion to CEO effective September 1. The orderly succession, unanimously approved by Apple's board, positions the 25-year hardware veteran to lead during the AI transition while Cook handles policy engagement. iPhone sales in China surged 23% in early 2026 against a shrinking market, providing Ternus with momentum heading into his first earnings call as CEO-designate. Investors seem convinced that product-focused leadership beats operational continuity in the AI era.

Meta stock fell 13% this week after the company raised 2026 capex guidance to $145 billion, driven by AI infrastructure and a Texas data center that ballooned from $1.5 billion to $10 billion. Legal defeats in New Mexico and Los Angeles compounded investor anxiety, while the company delayed rolling out a new AI model due to performance issues. Meta is simultaneously cutting hundreds of jobs to contain costs while pursuing what executives call "frontier ambition" in superintelligence. The 28% drop from recent highs reflects a broader reckoning: investors are no longer willing to fund massive AI bets without clear monetization timelines. Analysts still see 62% upside to $850, but that requires faith in returns years away.

Two of Europe's biggest equity cheerleaders just turned bearish for 2025. JPMorgan and UBS see minimal upside left in European markets this year, marking a decisive shift from their previous bullish stance. The timing matters: European equities are trading near historical discounts to US markets, but institutional flows suggest even value investors are losing patience. When the banks that typically talk their own book go negative, it signals either capitulation or genuine structural problems that cheaper valuations can't fix.

Equity markets took a breather without breaking their upward trajectory, suggesting institutional conviction behind recent gains. The pause feels more like profit-taking than trend reversal, with volume patterns indicating rotation rather than exit. Technology and financial stocks are holding their gains while defensive sectors lag, confirming the reflation trade remains dominant. The test comes next week when earnings season resumes and investors discover whether corporate guidance matches market optimism.